Research Article
Pontin Acts as a Potential Biomarker for Poor Clinical Outcome and Promotes Tumor Invasion in Hilar Cholangiocarcinoma
Figure 2
Overall survival curves of patients with hilar cholangiocarcinoma with respect to different Pontin expression. Patients with high Pontin expression had significantly poorer OS than those with low Pontin expression ().